MTOR and central nervous system cancer: The study identified eCF324 as a potent PI3K/mTOR inhibitor for GB, with EC50 values of 13 nM and 10 nM in U87 and T98 cell lines, respectively, and demonstrated strong synergistic effects with GDC0941, showing superior potency and high specificity for glioma cells.